Tag: drug development

October 31, 2023, ST. PETERSBURG, FL – Water Tower Research (www.watertowerresearch.com) has published an Initiation of Coverage Report on Filament Health Corp. (NE: FH) titled, “Pioneer in Botanical Psychedelics Drug Development”. The report can be accessed here. Stewarded by a […]

April 13th, 2021 – Ardigen, a global leader in artificial intelligence for drug discovery, is proud to announce that Guy Cavet, Ph.D. has joined the company’s Advisory Board.  This addition empowers Ardigen to continue expanding its technology and capabilities, and […]